about
Molecular targets of nutraceuticals derived from dietary spices: potential role in suppression of inflammation and tumorigenesisDistinct Functions of Neutrophil in Cancer and Its RegulationTherapeutic Implications for Overcoming Radiation Resistance in Cancer TherapyExploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunitiesCancer prevention with promising natural products: mechanisms of action and molecular targetsNSK-01105, a novel sorafenib derivative, inhibits human prostate tumor growth via suppression of VEGFR2/EGFR-mediated angiogenesisReceptor tyrosine kinase (RTK) mediated tyrosine phosphor-proteome from Drosophila S2 (ErbB1) cells reveals novel signaling networksQuercetin inhibits angiogenesis mediated human prostate tumor growth by targeting VEGFR- 2 regulated AKT/mTOR/P70S6K signaling pathwaysPhysicochemical properties and in vitro cytotoxicity of iron oxide-based nanoparticles modified with antiangiogenic and antitumor peptide A7R.Expression of vascular endothelial growth factor receptor 2 (VEGFR-2), inducible nitric oxide synthase (iNOS), and Ki-M1P in skull base chordoma: a series of 145 tumors.The -271 G>A polymorphism of kinase insert domain-containing receptor gene regulates its transcription level in patients with non-small cell lung cancer.Development of the anti-VEGF aptamer to a therapeutic agent for clinical ophthalmology.Delivery of curcumin by directed self-assembled micelles enhances therapeutic treatment of non-small-cell lung cancer.Active angiogenesis in metastatic renal cell carcinoma predicts clinical benefit to sunitinib-based therapy.ABCC5 supports osteoclast formation and promotes breast cancer metastasis to bone.Nobiletin Inhibits Angiogenesis by Regulating Src/FAK/STAT3-Mediated Signaling through PXN in ER⁺ Breast Cancer Cells.Imaging of VEGF receptor in a rat myocardial infarction model using PETA Phase II trial of tandutinib (MLN 518) in combination with bevacizumab for patients with recurrent glioblastoma.MMP-2 alters VEGF expression via alphaVbeta3 integrin-mediated PI3K/AKT signaling in A549 lung cancer cells.RLIP76 regulates HIF-1 activity, VEGF expression and secretion in tumor cells, and secretome transactivation of endothelial cells.Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1.A review on various targeted anticancer therapies.A widely applicable, high-throughput TR-FRET assay for the measurement of kinase autophosphorylation: VEGFR-2 as a prototype.Protein kinase LKB1 promotes RAB7-mediated neuropilin-1 degradation to inhibit angiogenesis.Understanding disease mechanisms with models of signaling pathway activities.Luteolin inhibits human prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis.Clinical experience with angiogenesis signaling inhibitors: focus on vascular endothelial growth factor (VEGF) blockers.The role of chalcones in suppression of NF-κB-mediated inflammation and cancer.A zebrafish in vivo phenotypic assay to identify 3-aminothiophene-2-carboxylic acid-based angiogenesis inhibitors.The vascular-ablative agent VEGF(121)/rGel inhibits pulmonary metastases of MDA-MB-231 breast tumors.Inhibition of prostate cancer osteoblastic progression with VEGF121/rGel, a single agent targeting osteoblasts, osteoclasts, and tumor neovasculature.Chemoprevention of prostate cancer by d,l-sulforaphane is augmented by pharmacological inhibition of autophagyOral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model.Antihormonal agents as a strategy to improve the effect of chemo-radiation in cervical cancer: in vitro and in vivo studyTanshinone IIA inhibits HIF-1α and VEGF expression in breast cancer cells via mTOR/p70S6K/RPS6/4E-BP1 signaling pathway.Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells.Targeting inflammatory pathways by triterpenoids for prevention and treatment of cancer.A method to assess target gene involvement in angiogenesis in vitro and in vivo using lentiviral vectors expressing shRNAUnfolded protein response is required in nu/nu mice microvasculature for treating breast tumor with tunicamycin.Diagnosis, treatment, and follow-up of medullary thyroid carcinoma: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism.
P2860
Q24630499-9442D836-4006-486B-98CC-32874B4B2259Q26773228-AAE69C81-47F0-4765-9F2A-4DC18F7F8BBBQ26777016-C0B43749-B571-48BF-8C21-09675F40DAF9Q26828930-89401EFA-93DB-4372-ADCF-9F2D37A8D628Q27006530-7C05D4F7-458A-4FC5-B75C-16502EBB54B1Q27320669-FF727F66-26C9-481F-9CE9-3991DB97B84BQ28473351-9D5A7BD9-E0F8-4D0E-8B78-CE47A183233EQ28484486-E60C1958-D7EE-43FF-BE3B-8E398AFB41A7Q30847079-F006027C-E4F3-4908-BDD6-B23835090548Q33274913-4E9DE392-6353-4893-B2FB-78D97A8D1616Q33444299-E48B5735-BA8C-4DE2-BDA7-3012879B42D3Q33492343-4DB705AF-3104-4C19-948B-C657CD44CEB7Q33553570-E0B47569-1D29-4F9A-A378-C8B667861DF0Q33682981-B1A65D59-C9A3-405A-82A8-BE5C4DA9254FQ33739392-3AB54384-CD4E-4EE7-BB9A-B2C0C565620EQ33754877-31C29F9D-A812-4B37-9FDA-41F9B093EA4CQ33786497-E89638F1-06C5-44F5-9413-5F9568FA7286Q33913465-F9571522-E7AC-4778-8197-B7937F69472FQ33938788-03580439-458F-45A1-B704-A779E4C0E21CQ34072657-B695E8D4-6226-44BC-81D7-7286F0A37C18Q34130059-16264AED-00D3-4FE8-A027-97321D51CD12Q34164735-E7C7BF48-D518-484D-826B-01DCF1549B08Q34271083-643FB3D6-4CD5-498E-891C-24B98C63AE59Q34311557-63E9B17F-6896-459C-AB72-1E87D38AD3DFQ34422921-06A59650-2658-4266-8FE3-F513F4BDFE87Q34540533-1ABEF7A4-8ACC-4834-B54B-A3D9FFB46CCFQ34608643-4306152B-E881-4195-82B8-56D88572A270Q34682265-8626D098-3DA1-48AD-98F4-FF74E2EE8679Q34729910-52E060EA-2EE4-4D09-B35B-DF3F048AB365Q34768492-03C58D2E-420B-455C-A0F4-18448E458B18Q34809729-7D8F8C42-9CF0-48E1-A0C9-74401C299CA3Q34900685-1D8EFC36-94B9-4748-AF81-F928FF705473Q35000546-FE57BF4A-4096-4642-8853-8AE123BAC4A8Q35030216-CF729751-3736-47A5-B7D6-4CFD22402FAFQ35058837-94D23FF7-74B5-4893-B1B0-6452A9F3991AQ35082888-68E79294-F79C-4754-9840-D0449DE6C33CQ35155622-6EE7A7E2-F059-43EE-BD11-D7A42D3706FBQ35156024-081FDBB9-B347-4D90-9EAD-06A504A0D790Q35309992-878E3C42-A3AC-435C-8F2E-22D2268BD715Q35396089-DE8F6F24-DF33-461E-9200-B403E7D7B9C5
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
VEGF receptor signaling in tumor angiogenesis.
@ast
VEGF receptor signaling in tumor angiogenesis.
@en
type
label
VEGF receptor signaling in tumor angiogenesis.
@ast
VEGF receptor signaling in tumor angiogenesis.
@en
prefLabel
VEGF receptor signaling in tumor angiogenesis.
@ast
VEGF receptor signaling in tumor angiogenesis.
@en
P1433
P1476
VEGF receptor signaling in tumor angiogenesis.
@en
P2093
P356
10.1634/THEONCOLOGIST.5-SUPPL_1-3
P478
P577
2000-01-01T00:00:00Z